Turner syndrome is diagnosed through a chromosome analysis, most often performed on a blood sample. The test looks for a missing or partially missing X chromosome in females. While the genetic test itself is straightforward, the path to getting tested varies widely. The median age at diagnosis is 15.1 years, meaning many girls and women go undiagnosed well into adolescence or adulthood.
When Turner Syndrome Is Suspected
Turner syndrome can be flagged at three broad stages of life: before birth, during infancy, or later in childhood and adolescence. Each stage has its own telltale signs that prompt a doctor to order genetic testing.
Before birth, the condition sometimes shows up on routine ultrasound. Fluid accumulation at the back of the neck, heart defects, or kidney abnormalities can all raise suspicion. Non-invasive prenatal testing (NIPT), a blood test that screens the mother’s blood for fetal DNA fragments, can also flag a high risk for the condition. NIPT detects Turner syndrome with a sensitivity of roughly 90 to 94%, depending on the method used, meaning it catches most but not all cases. A positive NIPT result is never considered a final diagnosis on its own.
At birth, some newborns show physical signs that lead to immediate testing. Puffy hands and feet caused by lymphatic fluid buildup, loose skin folds on the back of the neck, a webbed neck, and a broad chest with widely spaced nipples are the most recognizable features. Many newborns with Turner syndrome, though, appear only mildly affected and are not identified at this stage.
In childhood and adolescence, the most common red flag is short stature. A girl whose height falls below the 5th percentile with a slow growth rate will often be referred for genetic testing. During the teenage years, delayed or absent puberty is the other major trigger. About 33% of diagnoses happen between ages 10 and 17, and nearly 39% are not made until adulthood, often during a workup for infertility or missed periods.
The Chromosome Test That Confirms It
The gold standard for diagnosing Turner syndrome is a karyotype, a laboratory test that photographs and counts a person’s chromosomes. Current international guidelines from 2024 recommend analyzing a minimum of 30 cells from a blood sample. This high cell count matters because not every cell in the body may be affected. Some individuals have a mosaic form of Turner syndrome, where only a portion of their cells are missing an X chromosome while the rest are normal.
The diagnosis is confirmed when the karyotype reveals a 45,X pattern (one X chromosome instead of two) or shows a deletion on the short arm of an X chromosome. Several mosaic patterns also qualify, such as having some cells with 45,X and others with the typical 46,XX.
When results are needed quickly, such as for a newborn in intensive care, doctors may use faster methods like FISH (a fluorescent probe that highlights specific chromosomes) or microarray testing. These deliver preliminary results within days rather than the one to two weeks a full karyotype typically takes. However, guidelines specify that these rapid tests must be followed by a complete chromosome analysis to confirm the diagnosis.
Prenatal Diagnosis: NIPT, CVS, and Amniocentesis
If NIPT flags a high risk for Turner syndrome, the next step is a detailed ultrasound and an offer of invasive diagnostic testing. Two procedures can confirm the diagnosis before birth:
- Chorionic villus sampling (CVS) takes a tiny tissue sample from the placenta, usually performed between 11 and 14 weeks of pregnancy.
- Amniocentesis draws a small amount of amniotic fluid and is typically done after 14 weeks.
Both provide fetal cells that can be karyotyped. One important caveat: a prenatal diagnosis must be confirmed by a postnatal blood karyotype after the baby is born. Placental cells can sometimes have a different chromosomal makeup than the baby’s own cells, leading to a false result in either direction.
An interesting wrinkle in prenatal screening: when NIPT suggests Turner syndrome but the fetal ultrasound looks completely normal, the abnormal DNA fragments in the mother’s blood may actually be coming from the mother herself rather than the baby. In these cases, guidelines recommend offering the mother her own karyotype to check for a previously undiagnosed sex chromosome condition.
Hormone Levels as a Diagnostic Clue
Chromosome analysis is the definitive test, but hormone levels often provide supporting evidence, especially in girls who are being evaluated for delayed puberty. Turner syndrome typically causes primary ovarian insufficiency, meaning the ovaries don’t function as expected. This shows up as elevated levels of follicle-stimulating hormone (FSH) in the blood.
The pattern is age-dependent. In girls with Turner syndrome, FSH tends to be noticeably elevated during infancy (from birth to about age 5) and again during adolescence (after age 10). Between ages 5 and 10, hormone levels can look relatively normal, which is one reason the condition often goes undetected during those middle childhood years. An elevated FSH during the teenage years is a strong indicator of ovarian failure and will typically prompt a karyotype if one hasn’t already been done.
Why Diagnosis Is Often Delayed
Despite the availability of a simple blood test, Turner syndrome remains significantly underdiagnosed. Only about 15% of cases are identified before age 1. The rest are scattered across adolescence and adulthood, with a median diagnosis age of 15.1 years. Some women are not diagnosed until their 40s or later.
Several factors contribute to this delay. Girls with mosaic Turner syndrome may have milder features that don’t raise obvious flags. Short stature alone is common enough that it doesn’t always trigger genetic testing. And because Turner syndrome affects roughly 1 in 2,000 to 2,500 live female births, many primary care providers encounter it infrequently and may not think to test for it.
What Happens After a Positive Diagnosis
Once Turner syndrome is confirmed, a series of baseline screenings are recommended because the condition affects more than just growth and puberty. Congenital heart defects occur in 23 to 50% of individuals with Turner syndrome, so cardiovascular imaging with echocardiography is performed at the time of diagnosis regardless of age. The most common findings are a bicuspid aortic valve (present in 15 to 30% of cases) and a narrowing of the aorta called coarctation (7 to 18%).
If any signs of masculinization are present, such as unusual hair growth patterns or an enlarged clitoris, additional testing is done to check for Y chromosome material. This is important because the presence of Y chromosome fragments carries a risk of a specific type of gonadal tumor, and knowing about it early allows for monitoring or preventive action.
These initial screenings don’t change the genetic diagnosis itself, but they shape the management plan. Early identification of heart defects, hearing issues, thyroid problems, and kidney differences means they can be addressed before they cause complications, which is one of the strongest arguments for diagnosing Turner syndrome as early as possible.